avalglucosidase alfa

CHEBI:CHEBI_751970

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2565823
generic_name
avalglucosidase alfa
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
marketing_start_date
20210806
package_marketing_start_date
20210806
route
INTRAVENOUS
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_category
BLA
active_ingredient_strength
100 mg/10mL
labeler_name
Genzyme Corporation
manufacturer_name
Genzyme Corporation
pharm_class_epc
Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]
pharm_class
alpha-Glucosidases [CS]
pharm_class_cs
alpha-Glucosidases [CS]
nui
N0000175821
brand_name
Nexviazyme ngpt
brand_name_base
Nexviazyme
brand_name_suffix
ngpt
product_ndc
58468-0426
application_number
BLA761194
spl_id
90cb031c-63cf-4132-aedf-2e55dd989496
active_ingredient_name
AVALGLUCOSIDASE ALFA
package_ndc
58468-0426-1
package_description
1 VIAL, SINGLE-DOSE in 1 CARTON (58468-0426-1) / 10 mL in 1 VIAL, SINGLE-DOSE
unii
EO144CP0X9
spl_set_id
80eb3c9c-01d3-44fe-90ef-81df101b954d
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class